Abeona Therapeutics Inc.

NasdaqCM:ABEO 주식 보고서

시가총액: US$255.1m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Abeona Therapeutics 관리

관리 기준 확인 2/4

Abeona Therapeutics' CEO는 Vish Seshadri, Oct2021 에 임명되었습니다 의 임기는 2.67 년입니다. 총 연간 보상은 $ 2.85M, 19.5% 로 구성됩니다. 19.5% 급여 및 80.5% 보너스(회사 주식 및 옵션 포함). 는 $ 2.27M 가치에 해당하는 회사 주식의 1.22% 직접 소유합니다. 2.27M. 경영진과 이사회의 평균 재임 기간은 각각 2.7 년과 3.3 년입니다.

주요 정보

Vish Seshadri

최고 경영자

US$2.8m

총 보상

CEO 급여 비율19.5%
CEO 임기2.9yrs
CEO 소유권2.1%
경영진 평균 재임 기간2.9yrs
이사회 평균 재임 기간3.5yrs

최근 관리 업데이트

Recent updates

Is Abeona Therapeutics (NASDAQ:ABEO) Using Too Much Debt?

Sep 23
Is Abeona Therapeutics (NASDAQ:ABEO) Using Too Much Debt?

We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate

May 01
We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate

We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate

Jan 04
We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate

Here's Why We're Watching Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation

Aug 16
Here's Why We're Watching Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation

Can Abeona Therapeutics (NASDAQ:ABEO) Afford To Invest In Growth?

Mar 31
Can Abeona Therapeutics (NASDAQ:ABEO) Afford To Invest In Growth?

Abeona: Pivotal Data Readout EB-101 Before Year End Could Boost Shareholder Value

Oct 19

Abeona Therapeutics stock continues recent strong run, shares rise ~10%

Oct 04

Abeona Therapeutics GAAP EPS of -$2.08, revenue of $1M

Aug 11

Abeona therapeutics regains compliance with Nasdaq minimum bid price requirement

Jul 20

Abeona crashes 21% as reverse stock split takes effect

Jul 05

Here's Why Abeona Therapeutics (NASDAQ:ABEO) Must Use Its Cash Wisely

Mar 02
Here's Why Abeona Therapeutics (NASDAQ:ABEO) Must Use Its Cash Wisely

Here's Why Abeona Therapeutics (NASDAQ:ABEO) Can Manage Its Debt Despite Losing Money

Aug 17
Here's Why Abeona Therapeutics (NASDAQ:ABEO) Can Manage Its Debt Despite Losing Money

Abeona Therapeutics shares rise after letter to stockholders

May 26

Despite Lacking Profits Abeona Therapeutics (NASDAQ:ABEO) Seems To Be On Top Of Its Debt

Apr 28
Despite Lacking Profits Abeona Therapeutics (NASDAQ:ABEO) Seems To Be On Top Of Its Debt

Independent Director Paul Mann Just Sold A Bunch Of Shares In Abeona Therapeutics Inc. (NASDAQ:ABEO)

Feb 21
Independent Director Paul Mann Just Sold A Bunch Of Shares In Abeona Therapeutics Inc. (NASDAQ:ABEO)

How Much Did Abeona Therapeutics'(NASDAQ:ABEO) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 19
How Much Did Abeona Therapeutics'(NASDAQ:ABEO) Shareholders Earn From Share Price Movements Over The Last Three Years?

What Kind Of Investors Own Most Of Abeona Therapeutics Inc. (NASDAQ:ABEO)?

Dec 15
What Kind Of Investors Own Most Of Abeona Therapeutics Inc. (NASDAQ:ABEO)?

CEO 보상 분석

Vish Seshadri 의 보수는 Abeona Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-US$53m

Mar 31 2024n/an/a

-US$77m

Dec 31 2023US$3mUS$555k

-US$54m

Sep 30 2023n/an/a

-US$45m

Jun 30 2023n/an/a

-US$39m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$1mUS$505k

-US$43m

Sep 30 2022n/an/a

-US$83m

Jun 30 2022n/an/a

-US$84m

Mar 31 2022n/an/a

-US$91m

Dec 31 2021US$2mUS$255k

-US$85m

보상 대 시장: Vish 의 총 보상 ($USD 2.85M )은 US 시장( $USD 1.62M ).

보상과 수익: 회사가 수익성이 없는 동안 Vish 의 보상이 증가했습니다.


CEO

Vish Seshadri (48 yo)

2.9yrs

테뉴어

US$2,847,442

보상

Dr. Vishwas Seshadri, also known as Vish, Ph.D. & M.B.A., serves as Chief Executive Officer, President and Director at Abeona Therapeutics Inc. since October 15, 2021. He served as the Senior Vice Presiden...


리더십 팀

이름위치테뉴어보상소유권
Vishwas Seshadri
President2.9yrsUS$2.85m2.13%
$ 5.4m
Joseph Vazzano
Chief Financial Officer2.5yrsUS$1.49m0.86%
$ 2.2m
Brendan O'Malley
Senior VP & General Counsel4.4yrsUS$1.17m0.65%
$ 1.6m
Brian Kevany
Senior VP3.3yrs데이터 없음데이터 없음
Gregory Gin
Vice President of Investor Relations & Corporate Communicationsno data데이터 없음데이터 없음
Alison Hardgrove
Chief People Officer2.7yrs데이터 없음데이터 없음
Jon Voss
VP & Head of Quality2.9yrs데이터 없음데이터 없음
Madhav Vasanthavada
Senior VPless than a year데이터 없음데이터 없음
Carl Denny
Senior Vice President of Regulatory Affairsno data데이터 없음데이터 없음

2.9yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 관리: ABEO 의 관리팀은 경험 ( 2.7 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Vishwas Seshadri
President2.9yrsUS$2.85m2.13%
$ 5.4m
Mark Alvino
Independent Director3.5yrsUS$336.14k0.17%
$ 426.1k
Faith Charles
Independent Director3.5yrsUS$336.14k0.26%
$ 669.9k
Donald Wuchterl
Independent Director3.4yrsUS$330.52k0.26%
$ 674.5k
Eric Crombez
Independent Directorless than a year데이터 없음0.025%
$ 65.1k
Christine Berni-Silverstein
Independent Director4.5yrsUS$324.89k0.23%
$ 574.1k
Leila Alland
Independent Director3.4yrsUS$336.14k0.27%
$ 696.6k
Steven Gray
Member of Scientific Advisory Board7.4yrs데이터 없음데이터 없음
Erika Augustine
Member of Scientific Advisory Board7.4yrs데이터 없음데이터 없음
Jonathon Mink
Member of Scientific Advisory Board7.4yrs데이터 없음데이터 없음
John Cooper
Member of Scientific Advisory Board7.4yrs데이터 없음데이터 없음
Michael Amoroso
Chairman of the Board3.5yrsUS$351.14k0.33%
$ 850.3k

3.5yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 이사회: ABEO 의 이사회경험(평균 재직 기간 3.3 년)으로 간주됩니다.